Pricing Log in Create free account
Friday 6 November 2026 Export BRKR’s income statement to Excel — free account

Bruker Corporation

BRKR Healthcare Medical Devices

Bruker Corporation’s revenue for fiscal 2025 (year ended December 2025) was $3.4 billion, up 2.08% from fiscal 2024.

Revenue
+1.57%
EPS
−75.4%
Free cash flow
+278.7%
Total debt
−14.7%

Quarter to September 2026, against a year earlier

61.20 3.14 +5.41%
Market cap
$8.9B
P/E
0.0×
Fwd P/E
−412×
Dividend yield
0.33%
F-score
4/9
Altman Z
2.43
Beneish M
−2.56
Dividend safety
34/100
Overview Business Profile Earnings & Analysis
Financials
Income Statement Balance Sheet Cash Flow Metrics & Ratios
Segments Valuation Filings

Bruker Corporation 10-K filed Feb 27, 2026

Fiscal year 2025 · Period ended Dec 31, 2025 · Filed · accepted 4:04 PM ET · Document on sec.gov · Filing index

What changed

Item 1, Business Item 1A, Risk Factors Item 7, Management’s Discussion and Analysis

Item 1A, Risk Factors, against the 10-K filed Mar 3, 2025: 36 added · 13 removed · 71 modified; 2 with only figures updated; 1 moved without change